|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/26/22 Sanara MedTech Inc. S-8 8/26/22 9:538K M2 Compliance LLC/FA |
Document/Exhibit Description Pages Size
1: S-8 Registration Statement - Securities for an HTML 113K
Employee Benefit Plan
2: EX-5.1 Opinion of Counsel re: Legality HTML 17K
3: EX-23.1 Consent of Expert or Counsel HTML 7K
4: EX-23.2 Consent of Expert or Counsel HTML 6K
9: EX-FILING FEES Filing Fees HTML 21K
5: EX-99.2 Miscellaneous Exhibit HTML 76K
6: EX-99.3 Miscellaneous Exhibit HTML 77K
7: EX-99.5 Miscellaneous Exhibit HTML 110K
8: EX-99.6 Miscellaneous Exhibit HTML 110K
Exhibit 107
Calculation of Filing Fee Tables
FORM S-8
(Form Type)
Sanara MedTech Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1)(2) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee(3) | |||||||||||||||
| Equity | Common Stock, par value $0.001 per share(4) | Other | 104,007 | $ | 12.02 | $ | 1,250,164.14 | $92.70 per $1,000,000 | $ | 115.89 | ||||||||||||
| Equity | Common Stock, par value $0.001 per share(4) | Other | 40,184 | $ | 7.32 | $ | 294,146.88 | $92.70 per $1,000,000 | $ | 27.27 | ||||||||||||
| Equity | Common Stock, par value $0.001 per share(5) | Other | 11,500 | $ | 6.00 | $ | 69,000.00 | $92.70 per $1,000,000 | $ | 6.39 | ||||||||||||
| Total Offering Amounts | $ | 1,613,311.02 | $ | 149.55 | ||||||||||||||||||
| Total Fee Offsets | $ | 0.00 | ||||||||||||||||||||
| Net Fee Due | $ | 149.55 | ||||||||||||||||||||
| (1) | The Registration Statement on Form S-8 (the “Registration Statement”) to which this exhibit relates registers (i) 11,500 shares of common stock, par value $0.001 per share (“Common Stock”), of Sanara MedTech Inc. (the “Company”) issuable pursuant to the exercise of stock options issued under the Sanara MedTech Inc. Restated 2014 Omnibus Long Term Incentive Plan (the “2014 LTIP”) and (ii) 144,191 shares of Common Stock issuable upon exercise of stock options outstanding under the Precision Healing Inc. 2020 Stock Option and Grant Plan (the “Precision Healing Plan”) and assumed by the Company on April 4, 2022 pursuant to an Agreement and Plan of Merger (the “Merger Agreement”), by and among the Company, United Wound and Skin Solutions, LLC, a Delaware limited liability company and wholly owned subsidiary of the Company, Precision Healing Inc., a Delaware corporation, PH Merger Sub I, Inc., a Delaware corporation, PH Merger Sub II, LLC, a Delaware limited liability company, and Furneaux Capital Holdco, LLC (d/b/a BlueIO), solely in its capacity as the representative of the securityholders of Precision Healing. | |
| (2) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), the number of shares registered under the Registration Statement also includes an indeterminable number of shares of Common Stock as may be issued in connection with stock splits, stock dividends or similar transactions. | |
| (3) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(h) under the Securities Act. | |
| (4) | Represents shares of Common Stock issuable upon exercise of stock options outstanding under the Precision Healing Plan and assumed by the Company pursuant to the Merger Agreement. | |
| (5) | Represents shares of Common Stock issuable pursuant to the exercise of stock options issued under the 2014 LTIP. |
C:
| This ‘S-8’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on / Effective on: | 8/26/22 | |||
| 4/4/22 | 8-K | |||
| List all Filings | ||||